Follow
Ozge Gumusay
Ozge Gumusay
UCSF Helen Diller Family Comprehensive Cancer Center
Verified email at ucsf.edu
Title
Cited by
Cited by
Year
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival …
MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ...
Breast cancer 21, 677-683, 2014
462014
Diagnostic potential of serum direct markers and non‐invasive fibrosis models in patients with chronic hepatitis B
Ö Gümüşay, S Özenirler, A Atak, C Sönmez, S Özkan, AF Tuncel, ...
Hepatology Research 43 (3), 228-237, 2013
442013
Pembrolizumab for early triple-negative breast cancer
B Cetin, O Gumusay, P Schmid, R Dent, J O’Shaughnessy
N Engl J Med 382 (26), e108, 2020
432020
Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C
GA Seren Ozenirler, Gulbanu Erkan, Ozlem Gulbahar, Ozge (Gumusay) Bostankolu ...
Turk J Gastroenterol 22 (1), 47-53, 2011
402011
Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer
LA Huppert, O Gumusay, D Idossa, HS Rugo
CA: A Cancer Journal for Clinicians 73 (5), 480-515, 2023
352023
Immunotherapy toxicity: Identification and management
O Gumusay, J Callan, HS Rugo
Breast Cancer Research and Treatment 192 (1), 1-17, 2022
322022
Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites
O Gumusay, M Benekli, O Ekinci, M Baykara, A Ozet, U Coskun, ...
Japanese journal of clinical oncology 45 (5), 416-421, 2015
312015
Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology)
MA Kaplan, A Isikdogan, D Koca, M Kucukoner, O Gumusay, R Yildiz, ...
Oncology 83 (3), 141-150, 2012
282012
Oral etoposide for platinum-resistant and recurrent epithelial ovarian cancer: a study by the Anatolian Society of Medical Oncology
M KÜÇÜKÖNER, A Isikdogan, S Yaman, O Gumusay, O Unal, A Ulas, ...
Asian Pacific Journal of Cancer Prevention 13 (8), 2012
272012
Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme
B Cetin, II Gonul, O Gumusay, I Bilgetekin, E Algin, A Ozet, A Uner
Neuropathology 38 (5), 457-462, 2018
262018
Advances of molecular targeted therapy in gastric cancer
B Cetin, O Gumusay, M Cengiz, A Ozet
Journal of gastrointestinal cancer 47, 125-134, 2016
252016
Association between hemoglobin, calcium, and lactate dehydrogenase variability and mortality among metastatic renal cell carcinoma
B Cetin, B Afsar, SM Deger, II Gonul, O Gumusay, A Ozet, M Benekli, ...
International urology and nephrology 46, 1081-1087, 2014
222014
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology
O Gumusay, U Coskun, T Akman, AS Ekinci, M Kocar, ÖB Erceleb, ...
Journal of cancer research and clinical oncology 140, 151-157, 2014
182014
Factors influencing chemotherapy goal perception in newly diagnosed cancer patients
O Gumusay, B Cetin, M Benekli, G Gurcan, MN Ilhan, B Bostankolu, ...
Journal of Cancer Education 31, 308-313, 2016
162016
Emerging treatment strategies for metastatic triple-negative breast cancer
LA Huppert, O Gumusay, HS Rugo
Therapeutic advances in medical oncology 14, 17588359221086916, 2022
152022
Yaşlı Hastalarda Kanser Kemoterapisi.
Ö Bostankolu, B Öztürk, U Coşkun, S Büyükberber, M Benekli
UHOD: International Journal of Hematology & Oncology/Uluslararasi Hematoloji …, 2008
152008
Small cell neuroendocrine carcinoma of the posterior tongue
O Gumusay, G Yilmaz, U Aydil, A Ozet, G Tufan, O Erdem, Y Kizil, ...
Journal of Cancer Research and Therapeutics 11 (3), 651, 2015
122015
CDK4/6 inhibitors: mechanisms of resistance and potential biomarkers of responsiveness in breast cancer
B Cetin, CA Wabl, O Gumusay
Future Oncology 18 (9), 1143-1157, 2022
112022
Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology
O Ercelep, TO Topcu, IV Bayoglu, AS Ekinci, S Koca, H Kavgaci, ...
Tumor Biology 37 (9), 12033-12038, 2016
112016
The DNA damaging revolution
B Cetin, CA Wabl, O Gumusay
Critical Reviews in Oncology/Hematology 156, 103117, 2020
102020
The system can't perform the operation now. Try again later.
Articles 1–20